Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 289 Million | USD 578 Million | 6.9% | 2021 |
The global Blood Ketone Meter Market accrued earnings worth approximately 289 (USD Million) in 2021 and is predicted to gain revenue of about 578(USD Million) by 2028, is set to record a CAGR of nearly 6.9% over the period from 2022 to 2028. The report offers assessment and analysis of the Blood Ketone Meter Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Million).
Ketones are manufactured by human body through breaking of fats and this process is referred to as ketosis. Human body manufactures ketones when there is lack of sugar supply in cells owing to reduced insulin proportions. Apparently, human body system starts breaking of fats for providing ketones as an optional energy source over sugar. Reportedly, ketosis results in loss of weight along with offering numerous benefits including appetite control as well as improvement in heart health through cholesterol reduction.
Growth of blood ketone meter market over forecast timespan can be attributed to surge in diabetes-related awareness leading to launching of new products for identifying glucose and ketone. A prominent increment in research activities by major players for designing multi-operational blood ketone meters will accentuate expansion of blood ketone meter industry. Rise in number of diabetics across globe will culminate into humungous demand for blood ketone meter industry over forecast timeline. As per CDC, nearly 27 million of U.S. population in 2020 was diagnosed for diabetes. Reportedly, in 2018, more than 2 lac Americans falling below 20 years age were diagnosed for diabetes.
Furthermore, industry players are collaborating with other major players for manufacturing blood ketone meters with new features. Manufacturers are introducing new products as per requirements of individuals. This, in turn, will create new growth avenues for blood ketone meter market. Nonetheless, evolving landscapes will upswing market trends.
Report Attributes | Report Details |
---|---|
Report Name | Blood Ketone Meter Market Size Report |
Market Size in 2021 | USD 289 Billion |
Market Forecast in 2028 | USD 578 Million |
Growth Rate | CAGR of 6.9% |
Number of Pages | 188 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | KETO-MOJO, APEX Biotechnology Corporation, Nova Biomedical Corporation, EKF Diagnostics, TaiDoc Technology Corporation, and Abbott Laboratories |
Segments Covered | By Application, By Product, By End-User, and By Region |
Base Year | 2021 |
Historical Year | 2015 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America To Account Lucratively Towards Total Market Share By 2028
Growth of blood ketone meter market in North America over forecast timescale is subject to presence of strong healthcare infrastructure in sub-continent. Rise in awareness related to significance of blood ketone meters will promulgate scope of market growth in upcoming years. Outbreak of COVID-19 pandemic and its massive impact experienced in countries such as the U.S. have enhanced product penetration in sub-continent.
By Application
By End-User
By Product
By Region
FrequentlyAsked Questions
Growth of blood ketone meter market Size over forecast timespan can be attributed to surge in diabetes-related awareness leading to launching of new products for identifying glucose and ketone.
According to Zion market research report, The global Blood Ketone Meter Market Size accrued earnings worth approximately 289 (USD Million) in 2021 and is predicted to gain revenue of about 578(USD Million) by 2028, is set to record a CAGR of nearly 6.9% over the period from 2022 to 2028.
North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to presence of strong healthcare infrastructure in sub-continent.
The key market participants include KETO-MOJO, APEX Biotechnology Corporation, Nova Biomedical Corporation, EKF Diagnostics, TaiDoc Technology Corporation, and Abbott Laboratories.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed